Lorvotuzumab mertansine Completed Phase 1 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
https://clinicaltrials.gov/ct2/show/IMGN901 in Combination With Lenalidomide and Dexamethasone